Navigation Links
LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition
Date:2/1/2010

rious adverse events reported. The trials were initiated and run by Peplin, Inc., acquired by LEO Pharma in September 2009.  

Results from REGION I and Ib will be presented at an upcoming meeting of the American Academy of Dermatology.

LEO Pharma expects to file for regulatory approval of the treatment in the U.S. and Europe in 2011.

About Actinic Keratosis

Actinic keratosis (AK) is a common pre-cancerous skin condition caused by sun exposure, which can develop into skin cancers if left untreated. The number of AK patients is both large and rapidly growing, and AK is a serious health problem.

About LEO Pharma

Founded more than 100 years ago, LEO Pharma is an independent, research-based specialty pharmaceutical company committed to the discovery and development of novel drugs for patients within the areas of Dermatology and Critical Care Medicine. Wholly owned by The LEO Foundation, the company is headquartered in Ballerup, Denmark, outside of Copenhagen, and is represented in more than 90 countries worldwide.  Employees number more than 3,000, with 550 scientists and specialists working to develop new chemical entities.

With a strong portfolio of approved products and a robust pipeline of treatments in development for conditions including psoriasis, eczema and actinic (solar) keratosis, LEO Pharma is one of the leading dermatology companies in the U.S. and the world.  

For more information about LEO Pharma, visit www.leopharma.com.

SOURCE LEO Pharma

RELATED LINKS'/>"/>

SOURCE LEO Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
2. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
3. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
6. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
7. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
8. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
9. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
11. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 CVS Health (NYSE: CVS ) officially announced ... locations that sustained heavy fire damage during protests last week.  ... Baltimore over the past week or so, our hearts ... CVS Health President and CEO Larry Merlo . "Our purpose ... health. There is no better way that we can fulfill that ...
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... addition of the "Cannulas Market by Product ... Infusion, Venous, Microcannula), Material (Plastic, Metal) & End ... to 2020" report to their offering. ... grow at a CAGR of 5.6% from 2015 ...
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did you ... inclusive? , Did you lose money in your investment in ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3
(Date:5/6/2015)... As Hilo Medical Center progressed ... Model, the hospital looked for new applications that ... processes. The leadership team realized that while many ... patient registration still required patients to apply ink-on-paper ... Stage 7 attestation fast approaching, Hilo looked for ...
(Date:5/6/2015)... 06, 2015 Corporate Executives Mark ... MEBC, an Alliance Award for excellence in consulting ... 2015, JDA’s annual user conference which brought together ... wholesale distribution sectors. This award recognizes MEBC, Inc. ... services that advance their supply chain performance and ...
(Date:5/6/2015)... The Beryl Institute announces the publication ... Experience Journal (PXJ), an international, open access, peer-reviewed journal ... improving patient experience. The second volume of PXJ supports ... helps align the voices engaged and provides the space ... association with The Beryl Institute, Volume 2, Issue 1 ...
(Date:5/6/2015)... Los Angeles (PRWEB) May 06, 2015 ... WaterAid, the #1 ranked international water, sanitation and hygiene ... work for communities across the world and it brings ... Lindsey Carnett, CEO of Marketing Maven. “The ongoing relationship ... the opportunities available for people to learn about and ...
(Date:5/6/2015)... Wolters Kluwer , a leading global provider ... that in a survey of nearly 16,000 clinicians who ... decision support resource improves the quality of care they ... in more than 170 countries worldwide viewed more than ... Germany alone, 95% of all university hospitals use UpToDate. ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3
... the Popular Dietary Supplement ... Lipidshield Plus(TM), MELBOURNE, ... retail presence has expanded again and LipidShield Plus(TM) is,now available at ... is the popular NATURAL breakthrough cholesterol,fighting product that has been clinically ...
... Damages Fully Accrued in Financial Statements, COLORADO SPRINGS, ... today announced it plans to appeal,the verdict in a ... District Court in the Southern District of New York. ... been accepted by the judge,following a review of post-trial ...
... with an ingenious new self-waxing device that enables them to ... scene in the 2008/09 World Cup season. , The device ... during a race. Its developers are now working with manufacturers, ... top-class international competition as early as next year. , Validated ...
... models now under development could enhance the design of ... their sporting potential. , The models, more sophisticated and ... design, produce unprecedentedly realistic simulations of how potential ball ... , This data can then be harnessed by ...
... What keeps a newly licensed nurse on the job" ... U.S., many of which are confronting serious nursing shortages. , Based ... September 2007 issue of American Journal of Nursing, the top ... improving nursing management and taking steps to reduce on-the-job stress. ...
... A series of mega events in,Hispanic communities around the ... Cholesterol Awareness Month. The next major,Heart Health event in ... 12:00 and 6:00 pm. The Festival de la Villita ... place at the,Health Supersite at 26th and Kostner in ...
Cached Medicine News:Health News:New Health Corp. Announces the Addition of Hannaford Bros., Kash N Karry and Sweet Bay Supermarkets to its Retail Outlets 2Health News:Spectranetics to Appeal Decision in Patent Litigation 2Health News:Spectranetics to Appeal Decision in Patent Litigation 3Health News:Speedier skis on course for World Cup glory 2Health News:Computer models help raise the bar for sporting achievement 2Health News:New nurses report job stress, need for better management 2Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 2Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 3Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 4Health News:Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month 5
Subretinal Fluid Cannula, Curved; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip; Curved at 65°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
Micro Vitreoretinal Cannula; Angled; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 65°, 1mm from Tip....
...
Medicine Products: